Future Science Group
Supplementary file 1.docx (20.33 kB)

Supplementary file 1: Immunotherapy versus standard chemotherapy for treatment of extensive-stage small-cell lung cancer: a systematic review

Download (20.33 kB)
posted on 2021-06-11, 10:49 authored by Xingyu LiuXingyu Liu, Huifang Xing, Hongbing Zhang, Hongyu Liu, Jun Chen

Supplementary Tables:

Table S1. Ongoing international clinical trials evaluating immunotherapy for ES-SCLC patients

Table S2. Quality assessment: risk of bias using the Cochrane Collaboration’s tool

Table S3. Additional characteristics of patients, with a comparison of immunotherapy and chemotherapy in the included trials

Table S4. Main outcomes of the included trials

Table S5. Summary of the data status for subgroup-analyses of OS among the included trials


This work was supported by grants from the National Natural Science Foundation of China (81773207), the Natural Science Foundation of Tianjin (17YFZCSY00840, 18PTZWHZ00240, 19YFZCSY00040), and the Special support program for High Tech Leader & Team of Tianjin (TJTZJH-GCCCXCYTD-2-6).